Women's experiences receiving abnormal prenatal chromosomal microarray testing results

Abstract

Purpose:Genomic microarrays can detect copy-number variants not detectable by conventional cytogenetics. This technology is diffusing rapidly into prenatal settings even though the clinical implications of many copy-number variants are currently unknown. We conducted a qualitative pilot study to explore the experiences of women receiving abnormal results from prenatal microarray testing performed in a research setting.Methods:Participants were a subset of women participating in a multicenter prospective study "Prenatal Cytogenetic Diagnosis by Array-based Copy Number Analysis." Telephone interviews were conducted with 23 women receiving abnormal prenatal microarray results.Results:We found that five key elements dominated the experiences of women who had received abnormal prenatal microarray results: an offer too good to pass up, blindsided by the results, uncertainty and unquantifiable risks, need for support, and toxic knowledge.Conclusion:As prenatal microarray testing is increasingly used, uncertain findings will be common, resulting in greater need for careful pre-and posttest counseling, and more education of and resources for providers so they can adequately support the women who are undergoing testing. © American College of Medical Genetics and Genomics.